​Schedules are subjec​t to change.​

Educational Objectives

Wednesday, November 6, Miami Neuro Nursing Symposium - Eighth Annual (6 Cat. 1)

Upon completion of this session, participants should be better able to:

• Describe experiences shared by stroke survivors that identify strategies they found useful to cope with the diagnosis. 

• Recognize the importance of a pre-hospital stroke evaluation to ensure that patients receive timely diagnosis and treatment.

• Describe the imaging modalities used to diagnose acute stroke.

• Recognize the utility and indications of imaging results in acute stroke.

• Determine the precise etiology of a stroke in order to minimize complications and prevent recurrence. 

• Describe the use of antithrombotic treatments for patients in the first days after acute ischemic stroke onset. 

• Recognize the importance of evaluating patients who present to the clinic with neurologic symptoms that may be consistent with stroke.

• Recognize the clinical features and diagnosis of convulsive status epilepticus in adults.

• Explain how causes, prognoses and treatments of status epilepticus differ in adults, and describe optimal evaluation and treatment requirements. 

• Demonstrate how to prepare for sustained success in certified stroke centers.

• Recognize best practices for maintaining high-reliability stroke centers.

• Explain the evaluation and initial management of injuries to the cervical spinal column in adults, including the appropriate use of imaging studies. 

• Recognize the clinical presentation of movement disorders: Parkinson’s disease, essential tremor and dystonia. 

• Demonstrate the need for timely medical management of Parkinson’s disease and determine what medications to avoid.

• Demonstrate proper guidance on how to manage the family and patient regarding postoperative expectations.

• Analyze the current data behind patient selection for thrombectomy.

• Recognize appropriate candidates who should be taken to the angiography suite.

• Examine current gaps in knowledge associated with patient selection for thrombectomy.​

Thursday, November 7, Miami Neuro Symposium - Ninth Annual (Day 1) (6 Cat. 1)

Learning Objectives

Upon completion of this session, participants should be better able to:

• Recognize triage patients who are possible candidates for IV TPA or endovascular treatment as stroke alerts.

• Describe proper patient selection of patients for IV TPA.

• Describe proper selection of patients for endovascular treatment.

• Explain common pitfalls for patient selection.

• Recognize and comply with Baptist Health’s stroke policy regarding acute stroke treatments.

• Examine the proper imaging workup in patients presenting with symptoms and signs of acute ischemic stroke.

• Recognize the advantages and disadvantages of CTA.

• Explain the pitfalls of CT perfusion.

• Analyze randomized trials, real-life registries and new devices in acute stroke thrombectomy.

• Recognize how antiplatelet therapy reduces the incidence of stroke in patients at high risk for atherosclerosis and in those with known symptomatic cerebrovascular disease.

• Identify several “rare” causes of stroke that most neurologists will encounter and describe the management of these conditions.

• Analyze current information on the efficacy and safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases and summarize key aspects of best practice.

• Assess recent data relevant to new technologies and emerging treatment strategies in cerebral arteriovenous malformations.

• Examine recent research advances in intracerebral hematoma and describe current management strategies.

• Illustrate a contemporary, evidence-based outline of the perioperative critical care management of patients with subarachnoid hemorrhage.

• Describe the evaluation and management of hematologic disorders associated with stroke. 

• Recognize the evaluation and management of heparin-induced-thrombocytopenia. 

• Identify common risk factors for PRES, RCVS and vasculitis. 

• Recognize typical and atypical presentation of PRES, RCVS and vasculitis.

Friday, November 8, Miami Neuro Symposium (Day 2) (6 Cat. 1)

Learning Objectives

Upon completion of this session, participants should be better able to:

• Explain multiple modalities of treatments that are of increasing interest in epilepsy.

• Describe recent behavioral clinical trials in epilepsy, including cognitive behavioral therapy, mindfulness, progressive muscle relaxation and self-management. 

• Explain why new therapies such as calcitonin gene-related peptide (CGRP) antagonists and neuromodulation devices are needed for the treatment of migraine.

• Describe CGRP antagonist treatments for patients with migraine.

• Examine neuromodulation treatments for patients with migraine.

• Review the American Headache Society’s position statement on integrating new migraine treatments into clinical practice.

• Describe various types of status epilepticus and explain appropriate treatment approaches. 

• Distinguish primary from secondary headaches.

• Examine an algorithmic approach to classifying and diagnosing primary headache disorders.

• Analyze diagnostic criteria for chronic migraine and other types of primary chronic daily headache.

• Recognize risk factors for migraine chronification. 

• Explain how to formulate a multidisciplinary treatment plan for patients with migraine.

• Examine the medical literature about the use of cannabis as a potential treatment for adults with essential tremor and appropriately disseminate information to patients regarding its use.

• Analyze current, clinical, state-of-the-art functional neurosurgery in the treatment of Parkinson's disease, tremor and dystonia.

• Demonstrate the importance of continuous objective measures in the optimal selection of deep brain stimulation candidates with Parkinson’s disease.

• Explain the recent technical advances in deep brain stimulation. 

• Examine the epidemiology, diagnosis and differential diagnosis of neuromuscular disorders.  

• Evaluate the clinical features of ALS.

• Accurately diagnose and manage the early cognitive manifestations of dementias.

• Recognize clinical, diagnostic and pathological aspects of specific dementia syndromes and describe the treatment, risk factors and prevention.

• Describe the diagnosis and differential diagnosis of multiple sclerosis and examine treatment options for acute exacerbations.  

• Recognize anti-seizure effects of cannabis and its use in treatment of Lennox Gastaut and Dravet syndromes.

• Critically examine the expanding range of evidence on the efficacy of these compounds in the management of different seizure types and epilepsy syndromes. 

• Examine the medical literature about the use of cannabis in other neurological conditions and appropriately disseminate information to patients regarding its use.

Accreditation and Credits

Baptist Health provides accredited continuing education (CME/CE) to doctors, nurses and allied health professionals.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 18 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

 

Osteopathic Medicine, Podiatric Medicine, Psychology and Physician Assistants
This activity has been approved for 18 credit hours by the Florida Boards of Medicine, Osteopathic Medicine, Podiatric Medicine, Psychology and the Florida Council of Physician Assistants. CE Broker #s for Wednesday: 20-731928 (6 credits), Thursday: 20-731952 (6 credits) and Friday: 20-731960 (6 credits).

Dietary
This activity has been approved by the Commission on Dietetic Registration for 18 CPEUs. 

Nursing
This activity has been approved for a total of 18 contact hours by Florida State Board of Nursing.  6 Credits for Wednesday (CE Broker #20-731928), 6 Credits for Thursday (CE Broker #20-731952) and 6 Credits for Friday (CE Broker #20-731960). 

Pharmacy
This activity has been approved for 18 contact hours by the Florida State Board of Pharmacy. 6 Credits for Wednesday (CE Broker #20-731928), 6 Credits for Thursday (CE Broker #20-731952) and 6 Credits for Friday (CE Broker #20-731960). 

Respiratory Therapy
This activity has been approved for a total of 18 contact hours for respiratory therapy personnel in the category of personal growth by the State of Florida, AHCA provider #RCE58.  6 Credits for Wednesday (CE Broker #20-731928), 6 Credits for Thursday (CE Broker #20-731952) and 6 Credits for Friday (CE Broker #20-731960). 

Important Notice Regarding Partial Credit and Attendance 

Physicians: should claim only the credit commensurate with the extent of their participation in the symposium. 

Physician Assistants, Dietitians, Nurses, Pharmacists, Respiratory Therapists, Radiology Technologists: Sign-in and completion of an evaluation form are required in order to receive a certificate. Accrediting organizations require that attendees remain in the symposium for the entire session, in order to receive continuing education credit for that day. Therefore, certificates for each session will only be issued to those that attend a session in its entirety.  

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.​